Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

A population-based epidemiological study of neuromyelitis optica spectrum disorder in Hungary.

Papp V, Iljicsov A, Rajda C, Magyari M, Koch-Henriksen N, Petersen T, Jakab G, Deme I, Nagy F, Imre P, Lohner Z, Kovács K, Birkás AJ, Köves Á, Rum G, Nagy Z, Kerényi L, Vécsei L, Bencsik K, Jobbágy Z, Diószeghy P, Horváth L, Galántai G, Kasza J, Molnár G, Simó M, Sátori M, Rózsa C, Ács P, Berki T, Lovas G, Komoly S, Illes Z.

Eur J Neurol. 2019 Aug 29. doi: 10.1111/ene.14079. [Epub ahead of print]

PMID:
31465603
2.

Nationwide prevalence and incidence study of neuromyelitis optica spectrum disorder in Denmark.

Papp V, Illes Z, Magyari M, Koch-Henriksen N, Kant M, Pfleger CC, Roemer SF, Jensen MB, Petersen AE, Nielsen HH, Rosendahl L, Mezei Z, Christensen T, Svendsen K, Hyldgaard Jensen PE, Lydolph MC, Heegaard N, Frederiksen JL, Sellebjerg F, Stenager E, Petersen T.

Neurology. 2018 Dec 11;91(24):e2265-e2275. doi: 10.1212/WNL.0000000000006645. Epub 2018 Nov 9.

3.

Incidence of neuromyelitis optica spectrum disorder in the Central Denmark Region.

Dale GH, Svendsen KB, Gjelstrup MC, Christensen T, Houen G, Nielsen E, Bek T, Petersen T.

Acta Neurol Scand. 2018 Jun;137(6):582-588. doi: 10.1111/ane.12903. Epub 2018 Jan 22.

PMID:
29359475
4.

Application of the 2015 diagnostic criteria for neuromyelitis optica spectrum disorders in a cohort of Latin American patients.

Carnero Contentti E, Soto de Castillo I, Daccach Marques V, López PA, Antunes Barreira A, Armas E, de Aquino Cruz C, Rubstein A, Lavigne Moreira C, Molina OM, Soto A, Tkachuk V.

Mult Scler Relat Disord. 2018 Feb;20:109-114. doi: 10.1016/j.msard.2018.01.001. Epub 2018 Jan 6.

PMID:
29367170
5.

A nationwide epidemiological study on the prevalence of multiple sclerosis and neuromyelitis optica spectrum disorder with important multi-ethnic differences in Malaysia.

Viswanathan S, Wah LM.

Mult Scler. 2019 Oct;25(11):1452-1461. doi: 10.1177/1352458518792430. Epub 2018 Aug 16.

PMID:
30113245
6.

Evaluation of the 2015 diagnostic criteria for neuromyelitis optica spectrum disorder.

Hyun JW, Jeong IH, Joung A, Kim SH, Kim HJ.

Neurology. 2016 May 10;86(19):1772-9. doi: 10.1212/WNL.0000000000002655. Epub 2016 Apr 13.

PMID:
27164713
7.

Epidemiology of aquaporin-4 autoimmunity and neuromyelitis optica spectrum.

Flanagan EP, Cabre P, Weinshenker BG, Sauver JS, Jacobson DJ, Majed M, Lennon VA, Lucchinetti CF, McKeon A, Matiello M, Kale N, Wingerchuk DM, Mandrekar J, Sagen JA, Fryer JP, Robinson AB, Pittock SJ.

Ann Neurol. 2016 May;79(5):775-783. doi: 10.1002/ana.24617. Epub 2016 Apr 4.

8.

Validation of the 2015 diagnostic criteria for neuromyelitis optica spectrum disorders in a cohort of South Indian patients.

Kanikannan MA, Arepareddy PK, Mathukumalli NL, Y S, Kandadai RM, Jabeen AS, T S, Borgohain R.

Mult Scler Relat Disord. 2019 Jul 29;35:164-169. doi: 10.1016/j.msard.2019.07.024. [Epub ahead of print]

PMID:
31382202
9.

Epidemiology of NMOSD in Catalonia: Influence of the new 2015 criteria in incidence and prevalence estimates.

Sepúlveda M, Aldea M, Escudero D, Llufriu S, Arrambide G, Otero-Romero S, Sastre-Garriga J, Romero-Pinel L, Martínez-Yélamos S, Sola-Valls N, Armangué T, Sotoca J, Escartín A, Robles-Cedeño R, Ramió-Torrentà L, Presas-Rodríguez S, Ramo-Tello C, Munteis E, Pelayo R, Gubieras L, Brieva L, Ortiz N, Hervás M, Mañé-Martínez MA, Cano A, Vela E, Tintoré M, Blanco Y, Montalban X, Graus F, Saiz A.

Mult Scler. 2017 Oct 1:1352458517735191. doi: 10.1177/1352458517735191. [Epub ahead of print]

PMID:
28984163
10.

Epidemiology of NMOSD in Sweden from 1987 to 2013: A nationwide population-based study.

Jonsson DI, Sveinsson O, Hakim R, Brundin L.

Neurology. 2019 Jul 9;93(2):e181-e189. doi: 10.1212/WNL.0000000000007746. Epub 2019 Jun 6. Erratum in: Neurology. 2019 Oct 8;93(15):688.

11.

International consensus diagnostic criteria for neuromyelitis optica spectrum disorders.

Wingerchuk DM, Banwell B, Bennett JL, Cabre P, Carroll W, Chitnis T, de Seze J, Fujihara K, Greenberg B, Jacob A, Jarius S, Lana-Peixoto M, Levy M, Simon JH, Tenembaum S, Traboulsee AL, Waters P, Wellik KE, Weinshenker BG; International Panel for NMO Diagnosis.

Neurology. 2015 Jul 14;85(2):177-89. doi: 10.1212/WNL.0000000000001729. Epub 2015 Jun 19.

12.

Neuromyelitis optica spectrum disorders in Iran.

Eskandarieh S, Nedjat S, Azimi AR, Moghadasi AN, Sahraian MA.

Mult Scler Relat Disord. 2017 Nov;18:209-212. doi: 10.1016/j.msard.2017.10.007. Epub 2017 Oct 9.

PMID:
29141812
13.

Neuromyelitis optica spectrum disorders in Algeria: A preliminary study in the region of Tizi Ouzou.

Daoudi S, Bouzar M.

Mult Scler Relat Disord. 2016 Mar;6:37-40. doi: 10.1016/j.msard.2015.12.005. Epub 2015 Dec 17.

PMID:
27063620
14.

Clinical characteristics of late-onset neuromyelitis optica spectrum disorder: A multicenter retrospective study in Korea.

Seok JM, Cho HJ, Ahn SW, Cho EB, Park MS, Joo IS, Shin HY, Kim SY, Kim BJ, Kim JK, Cho JY, Huh SY, Kwon O, Lee KH, Kim BJ, Min JH.

Mult Scler. 2017 Nov;23(13):1748-1756. doi: 10.1177/1352458516685416. Epub 2017 Jan 6.

PMID:
28058965
15.

The impact of 2015 neuromyelitis optica spectrum disorders criteria on diagnostic rates.

Hamid SH, Elsone L, Mutch K, Solomon T, Jacob A.

Mult Scler. 2017 Feb;23(2):228-233. doi: 10.1177/1352458516663853. Epub 2016 Sep 28.

PMID:
27553618
16.

Clinical characteristics and long-term visual outcome of optic neuritis in neuromyelitis optica spectrum disorder: A comparison between Thai and American-Caucasian cohorts.

Vanikieti K, Poonyathalang A, Jindahra P, Bouzika P, Rizzo JF 3rd, Cestari DM.

Mult Scler Relat Disord. 2017 Oct;17:87-91. doi: 10.1016/j.msard.2017.07.013. Epub 2017 Jul 10.

PMID:
29055481
17.

Neuromyelitis optica spectrum disorders with antibodies to myelin oligodendrocyte glycoprotein or aquaporin-4: Clinical and paraclinical characteristics in Algerian patients.

Bouzar M, Daoudi S, Hattab S, Bouzar AA, Deiva K, Wildemann B, Reindl M, Jarius S.

J Neurol Sci. 2017 Oct 15;381:240-244. doi: 10.1016/j.jns.2017.08.3254. Epub 2017 Aug 31.

PMID:
28991690
18.

Prevalence and characteristics of transverse myelitis and neuromyelitis optica spectrum disorders in the United Arab Emirates: A multicenter, retrospective study.

Holroyd KB, Aziz F, Szolics M, Alsaadi T, Levy M, Schiess N.

Clin Exp Neuroimmunol. 2018 Aug;9(3):155-161. doi: 10.1111/cen3.12458. Epub 2018 May 7.

19.

A population-based study of neuromyelitis optica in Caucasians.

Asgari N, Lillevang ST, Skejoe HP, Falah M, Stenager E, Kyvik KO.

Neurology. 2011 May 3;76(18):1589-95. doi: 10.1212/WNL.0b013e3182190f74.

20.

Epidemiological, clinical and immunological aspects of neuromyelitis optica (NMO).

Asgari N.

Dan Med J. 2013 Oct;60(10):B4730. Review.

PMID:
24083534

Supplemental Content

Support Center